Share this post on:

Product Name: DRAK1 Antibody
Species Reactivity: Human
Tested Applications: ELISA, ICC, IF, WB
Applications: DRAK1 antibody can be used for detection of DRAK1 by Western blot at 1 μg/mL. An approximately 50 kDa band can be detected. Antibody can also be used for immunocytochemistry starting at 2 μg/mL. For immunofluorescence start at 10 μg/mL.
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 50 kDa
Immunogen: DRAK1 antibody was raised against a peptide corresponding to amino acids near the amino terminus of human DRAK1.The immunogen is located within the first 50 amino acids of DRAK1.
Host Species: Rabbit
Purification: DRAK1 Antibody is affinity chromatography purified via peptide column.
Physical State: Liquid
CAS NO.: 101917-30-0
Product: sodium 4-pentynoate
Buffer: DRAK1 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
Storage Conditions: DRAK1 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: DRAK1 Antibody: DRAK1, DRAK1, DAP kinase-related apoptosis-inducing protein kinase 1
Accession NO.: Q9UEE5
Protein Ino: 14423930
Official Symbol: STK17A
Geneid: 9263
Background: DRAK1 Antibody: Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 for DAP kinase-related apoptosis-inducing protein kinases. DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK1 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK1 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues.
PubMed ID:http://aac.asm.org/content/38/12/2896.abstract

Share this post on:

Author: Betaine hydrochloride